Skip to main content

Advertisement

Table 1 Demographic and clinical feature at the time of presentation of children with bacteremia from ESBL group and non ESBL group E. coli or Klebsiella spp.

From: Clinical epidemiology, risk factors and treatment outcomes of extended-spectrum beta-lactamase producing Enterobacteriaceae bacteremia among children in a Tertiary Care Hospital, Bangkok, Thailand

  Non-ESBL (n=45) ESBL (n=52) P-value
Sex (M:F) 26:19 27:25 0.334
Mean ± SD of age (month) 65 ± 81 69 ± 75 0.708
Mean ± SD of length of stay 37 ± 57 93 ± 180 0.083
Day 25 40 < 0.01
Underlying disease
 Hematological malignancy 8 15 0.463
 Solid tumor 2 2 0.661
 Nephrotic syndrome 2 3 1
 Congenital heart disease 1 12 < 0.01
 End stage renal disease 3 3 0.661
 SLE 0 2 0.497
 Preterm 7 0 < 0.01
 Newborn 2 1 0.595
 Chronic lung disease 0 2 0.497
 Neurological problem 4 4 0.729
Focal infection
 Pneumonia 10 21 0.17
 Urinary tract infection 13 14 0.58
 Diarrhea 1 5 0.18
 Cellulitis 1 3 0.54
 Ascending cholangitis 2 0 0.15
 Meningitis 2 2 0.72
Mortality (%) 6 (13.3%) 20 (38.9%) < 0.05
  1. ESBL group: patient with bacteremia caused by ESBL producing—E. coli or Klebsiella spp.
  2. Non-ESBL group: patient with bacteremia caused by non-ESBL producing—E. coli or Klebsiella spp.